Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies

被引:9
作者
Mosakowska, Magdalena [1 ]
Kania, Dorota Brodowska [1 ]
Szamotulska, Katarzyna [2 ]
Rymarz, Aleksandra [1 ]
Niemczyk, Stanislaw [1 ]
机构
[1] Mil Inst Med, Dept Internal Dis Nephrol & Dialysis, 128 Szaserow St, PL-04141 Warsaw, Poland
[2] Inst Mother & Child Hlth, Dept Epidemiol & Biostat, 17a Kasprzaka St, PL-01211 Warsaw, Poland
关键词
ANCA; vasculitis; microhematuria; CRP; ESR; procalcitonin; fibrinogen; d-dimer; complement system; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; C-REACTIVE PROTEIN; WEGENERS-GRANULOMATOSIS; DISEASE-ACTIVITY; FOLLOW-UP; GLOMERULONEPHRITIS; PROCALCITONIN; RELAPSE;
D O I
10.1186/s12882-021-02495-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The aim of the study was to assess the correlation of commonly used laboratory tests with clinical activity, degree of kidney involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies. Methods The study included 28 patients with active AAV (BVAS >= 3). The following tests were performed: MPO-ANCA, PR3-ANCA, peripheral blood count, ESR, CRP, procalcitonin, creatinine, GFR, urea, albumin, fibrinogen, d-dimer, components of the C3 and C4 complement systems, urinalysis with sediment evaluation and diurnal proteinuria. The assessments were conducted twice: at study entry (A0) and after 6 months (A6) (BVAS = 0). Results At the time of inclusion in the study, the mean creatinine concentration was 3.39 mg/dl (GFR 33.17 ml/min/1.73 m(2)), after achieving remission in 11 patients (39.3 %) GFR remained below 30 ml/min/1.73 m(2), 4 patients (14.3 %) continued renal replacement therapy, and 3 patients (10.7 %) with advanced renal failure died. Microscopic hematuria occurred in 80.9 % of the studied population, withdrew in most patients, strongly correlated with renal involvement p < 0.001 and was not related to disease severity p = 0.147. CRP, ESR, fibrinogen, d-dimer, albumin and hemoglobin in the peripheral blood showed a strong correlation with the clinical activity of AAV and well identified severe patients. High procalcitonin concentrations correlated with a severe form of the disease, pulmonary involvement with respiratory failure and alveolar hemorrhage (mean 3.41 ng/ml, median 0.91 ng/ml, SD 7.62, p = 0.000), and were associated with the occurrence of infectious complications and the need to administer antibiotic therapy. ANCA antibodies were useful in the evaluation of patients with AAV, the amount of antibodies did not correlate with the severity of vasculitis (p = 0.685) and the results in many patients did not match the expected assumptions. Conclusions CRP, ESR, fibrinogen, d-dimers, albumin and hemoglobin in the peripheral blood correlate well with the activity of vasculitis and identify severe patients. The resolution of microscopic hematuria suggests remission of the disease in the renal area. Procalcitonin may be slightly increased in patients with active AAV without infection, high concentrations are strongly associated with infectious complications. ANCA antibodies should always be interpreted in the context of the observed clinical symptoms.
引用
收藏
页数:9
相关论文
共 35 条
  • [1] High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients
    Allenbach, Y.
    Seror, R.
    Pagnoux, C.
    Teixeira, L.
    Guilpain, P.
    Guillevin, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 564 - 567
  • [2] Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis
    Augusto, Jean-Francois
    Langs, Virginie
    Demiselle, Julien
    Lavigne, Christian
    Brilland, Benoit
    Duveau, Agnes
    Poli, Caroline
    Chevailler, Alain
    Croue, Anne
    Tollis, Frederic
    Sayegh, Johnny
    Subra, Jean-Francois
    [J]. PLOS ONE, 2016, 11 (07):
  • [3] Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO
  • [4] 2-O
  • [5] The complement system in systemic autoimmune disease
    Chen, Min
    Daha, Mohamed R.
    Kallenberg, Cees G. M.
    [J]. JOURNAL OF AUTOIMMUNITY, 2010, 34 (03) : J276 - J286
  • [6] Investigations in systemic vasculitis. The role of the laboratory
    Csernok, Elena
    Bossuyt, Xavier
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2018, 32 (01): : 52 - 62
  • [7] Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/art.1780400709
  • [8] Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis
    Finkielman, Javier D.
    Merkel, Peter A.
    Schroeder, Darrell
    Hoffman, Gary S.
    Spiera, Robert
    St. Clair, E. William
    Davis, John C., Jr.
    McCune, W. Joseph
    Lears, Andrea K.
    Ytterberg, Steven R.
    Hummel, Amber M.
    Viss, Margaret A.
    Peikert, Tobias
    Stone, John H.
    Specks, Ulrich
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 147 (09) : 611 - 619
  • [9] Pathogenesis of ANCA-associated Vasculitis
    Flint, Julia
    Morgan, Matthew D.
    Savage, Caroline O. S.
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (03) : 463 - +
  • [10] Persistent or New Onset Microscopic Hematuria in Patients with Small Vessel Vasculitis in Remission: Findings on Renal Biopsy
    Geetha, Duvuru
    Seo, Philip
    Ellis, Carla
    Kuperman, Michael
    Levine, Stuart M.
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (07) : 1413 - 1417